Introduction
Recently, Emamian and colleagues demonstrated that ataxin-1 is phosphorylated at serine 776 (S776) and Spinocerebellar ataxia type 1 (SCA1) is an autosomal that substitution of this S776 residue with alanine (A776) dominant neurodegenerative disease caused by the greatly diminishes the ability of mutant ataxin-1 to agexpansion of a CAG repeat that produces an abnormally gregate (Emamian et al., 2003) . These results suggest long polyglutamine tract in the ataxin-1 protein. At least that a serine at position 776 of ataxin-1 plays a role in SCA1 pathogenesis. Because this serine is normally phosphorylated, we speculated that S776 phosphoryla- peptides matched the ⑀ and isoforms of 14-3-3, a we sought to identify proteins that interact with ataxinprotein family of multifunctional regulatory molecules 1-S776 but not ataxin-1-A776, to identify the kinase that (Fu et al., 2000) . phosphorylate S776 in ataxin-1, and examine the effects To verify the interaction between ataxin-1 and 14-of these factors on SCA1 pathogenesis.
3-3, we performed immunoprecipitation on lysates from COS1 cells transfected with FLAG-tagged ataxin-1 and Results a plasmid bi-cistronically expressing HA-tagged 14-3-3⑀ and myc-tagged 14-3-3 proteins ( Figure 1B ataxin-1 and 14-3-3 in vivo thus requires the serine resisis revealed several polypeptides that coprecipitated due at position 776 in ataxin-1. The sequence of ataxin-1 with ataxin-1 ( Figure 1A ). These proteins were purified (amino acids 773-778) is similar to a consensus 14-3-3 and subjected to trypsin digestion followed by mass binding motif (Fu et al., 2000) that comprises an essential spectrometry. A number of chaperones were detected phosphoserine residue flanked by an arginine and proin the immunoprecipitates of both ataxin-1[82Q]-S776 line ( Figure 1C ). This motif is present in ataxin-1 homoand ataxin-1[82Q]-A776, including inducible Hsp70, logs of different species, suggesting that the ataxin-1/ Hsc70, Hsp40, and BiP/GRP78 ( Figure 1A , and data not 14-3-3 interaction has been evolutionarily conserved. shown), which suggests that both forms of ataxin-1[82Q]
To probe whether the ataxin-1/14-3-3 interaction is adopt misfolded conformations readily recognized by direct or indirect, we performed a yeast two-hybrid heat shock proteins. ␤-actin and vimentin were also screen using an evolutionarily conserved C-terminal detected in the immunoprecipitates of both ataxin-1 fragment of ataxin-1 (amino acids 529-816, denoted "ataxin-1C288", which contains the postulated 14-3-3 variants. Interestingly, two proteins with apparent mo- (C) 14-3-3 binds most strongly to expanded ataxin-1. Lysates of COS1 cells transfected with FLAG-tagged ataxin-1 (2Q, 30Q, or 82Q) or a control plasmid (mock) were immunoprecipitated with anti-FLAG. The input and immunoprecipitates were resolved in SDS-PAGE, and immunoblotted with anti-FLAG, anti-ataxin-1-pS776, or mixtures of anti-14-3-3⑀ and anti-14-3-3 antibodies. Anti-14-3-3⑀ antibodies give weaker signals than anti-14-3-3 due to a lower affinity. 14-3-3 associates most strongly with ataxin-1[82Q] based on the amount immunoprecipitated relative the total amount of soluble ataxin-1 that can be immunoprecipitated. Ataxin-1 variants were phosphorylated similarly as revealed by the relative signal ratio of S776-phosphorylated ataxin-1 (p-ataxin-1) to total ataxin-1. Normalized quantification is shown. binding motif). 14-3-3 (␤ and ⑀) was the most frequently proteins in yeast, the polyglutamine tract itself is not required for ataxin-1/14-3-3 interactions. Nonetheless, identified interactor (data not shown). When we examined the ability of full-length ataxin-1 to interact with 14-double transformants of expanded ataxin-1[82Q] and 14-3-3 grew slightly faster than those of unexpanded 3-3 in the yeast two-hybrid system, we found that only ataxin-1[82Q]-S776 (but not A776) interacted with the ⑀, ataxin-1 (2Q or 30Q) and 14-3-3 on medium lacking leucine, tryptophan, histidine, and adenine ( Figure 2B ). This , and ␤ isoforms of 14-3-3 (Figure 2A , and data not shown).
observation suggests that 14-3-3 binds more strongly to mutant ataxin-1. To test the effect of polyglutamine To determine whether ataxin-1 interacts with different isoforms of 14-3-3 in vivo, we used isoform-specific tract length on ataxin-1/14-3-3 binding, we transfected COS1 cells with constructs encoding ataxin-1 bearing antibodies to detect 14-3-3 proteins in ataxin-1 immunoprecipitates from Neuro2A cells transfected with ataxineither 2Q, 30Q, or 82Q. Although the amounts of immunoprecipitated ataxin-1 decreased with longer gluta-1[82Q]-S776. Several 14-3-3 isoforms, including ⑀, , , ␥, and ␤, were detectable in the immunocomplex of mine tracts because of lower protein solubility, similar amounts of 14-3-3 coimmunoprecipitated with each ataxin-1 (data not shown).
protein ( Figure 2C) ; i.e., the relative amount of immunoprecipitated 14-3-3 was highest in cells transfected with 14-3-3 Associates Most Strongly with Expanded Ataxin-1 ataxin-1[82Q]. These differences could not be attributed to changes in the endogenous levels of 14-3-3 proteins, Because the ataxin-1C288 fragment that does not contain the polyglutamine tract can interact with 14-3-3 which did not differ in the transfected cells ( Figure 2C , input Figures 2B and 2C ). More importantly, with this antibody showed that ataxin-1 proteins were phosphorylated similarly irrespective of polyglutamine we found that 14-3-3 must interact directly with ataxin-1 to stabilize it. Ataxin-1[82Q]-A776, which is defective tract length ( Figure 2C) . Therefore, the differential abilities of ataxin-1 2Q, 30Q, and 82Q to interact with 14-in the 14-3-3 binding, resisted stabilization by 14-3-3 ( Figure 3C ). The differential effects of 14-3-3 on ataxin-1 3-3 are not attributable to different levels of phosphorylation. Rather, it is likely that expanded ataxin-1 [82Q] variants ruled out the possibility that 14-3-3 might generally enhance the transcription of the transgenes, since attains a certain conformation that is more favorable for 14-3-3 binding.
all of them are driven by the same promoter. These data suggest that 14-3-3 modulates mutant ataxin-1 toxicity by retarding ataxin-1 degradation. 14-3-3 Stimulates Ataxin-1 Inclusion Formation We examined the subcellular localization of ataxin-1 and 14-3-3 in COS1 cells. In cells transfected with 14-3-3 14-3-3 Aggravates Neurodegeneration in SCA1 Flies alone, 14-3-3 distributed to both the cytoplasm and nucleoplasm ( Figure 3A We tested the effects of different levels of 14-3-3 on had a much more severe phenotype than those expressing ataxin-1[82Q] alone, showing profoundly disordered ataxin-1 inclusion formation. To achieve a condition of 14-3-3 overexpression, we cotransfected COS1 cells ommatidia, a thin and disorganized retina layer, and grossly abnormal rhabdomeres ( Figure 4A , panels 3 and with 14-3-3 and ataxin-1 at a higher molar ratio (5:1, 14-3-3 to ataxin-1) than the 1:1 ratio used earlier (cf., Figure  6 , and data not shown). This aggravated phenotype was observed in SCA1 82Q /d14-3-3⑀ double transgenic flies 3A). 14-3-3 overexpression had little effect on ataxin-1[82Q]-A776, which remained evenly distributed in the derived from different individual weak lines for both transgenes (data not shown). 14-3-3 thus intensifies nucleoplasm of most transfectants ( Figure 3B , panels 4 to 6). Rare ataxin-1[82Q]-A776 aggregates were deataxin-1-induced neurodegeneration in a fly model of SCA1. tected in some transfectants, but in these cells, 14-3-3 was evenly distributed and did not redistribute to the site of the inclusions ( Figure 3B , panels 4 to 6, arrowhead). ataxin-1 toxicity was greatly enhanced in animals car-UAS promoter might give rise to low expression of ataxin-1 that gradually accumulates in the presence of rying overexpression alleles of d14-3-3⑀.
14-3-3 Stabilizes Ataxin-1 in SCA1 Flies
Oddly, this early lethality of SCA1 82Q /d14-3-3⑀ double leaky d14-3-3⑀ expression due to the latter's stabilization effect upon ataxin-1. We therefore examined the transgenic animals occurred even in the absence of gmr-GAL4 driver. We speculated that the leakage-prone larvae of SCA1 82Q /d14-3-3⑀ double transgenic animals The importance of Akt phosphorylation for the association of ataxin-1 and 14-3-3 was examined using an in substrate of Akt kinase, we performed an in vitro phos- To investigate the possibility that sequestration of 14-folding and ubiquitin-proteasome pathways, such as 3-3 with mutant ataxin-1 interferes with the cellular funcchaperones and Ube3a ligase, are trans-acting modulations of 14-3-3, we evaluated the effects of 14-3-3 overtors for ataxin-1's toxicity in cells, flies, and mice (reviewed expression on the SCA1 phenotype in vivo and found in Zoghbi and Botas, 2002) . A recently discovered cisno evidence that loss of 14-3-3 cellular functions plays acting factor is serine 776, which is phosphorylated in a major role in SCA1 pathogenesis. If SCA1 pathology vivo (Emamian et al., 2003 ). An S776A mutation abolwas caused simply by sequestration of 14-3-3 by ished the ability of ataxin-1[82Q] to induce neurodegenataxin-1, one would expect exogenous 14-3-3 to superation in transgenic mice even when ataxin-1 harbored press the phenotype-yet overexpression of 14-3-3 in an expanded polyglutamine tract and was localized to SCA1 flies aggravated degeneration. In fact, immunothe nucleus (Emamian et al., 2003) . This finding underlabeling of cerebellar sections from transgenic mice ovscored the role of S776 in SCA1 pathogenesis. In this erexpressing ataxin-1[82Q]-S776 revealed that the disstudy, we probed the mechanism by which the S776 tribution of 14-3-3 remains grossly unchanged without residue confers toxicity onto ataxin-1[82Q]. We found sequestration into nuclear inclusions (data not shown); that, upon Akt-dependent phosphorylation, S776 medithe colocalization of the two proteins to inclusions in ates the interaction of ataxin-1 with 14-3-3.
cell cultures could be modulated by differences in other cellular proteins or the nature of inclusions (formed over hours in cells versus days and weeks in mice). It is 14-3-3 Modulates SCA1 Pathogenesis by Stabilizing Ataxin-1 likely that 14-3-3 and ataxin-1 preferentially form soluble protein complexes in vivo, whereby only a minor fraction 14-3-3 proteins bind to phosphopeptide motifs in a variety of cellular proteins to regulate diverse biological of 14-3-3 is present in nuclear aggregates. Consistent with the notion that polyglutamine expanprocesses such as signal transduction, cell cycle control, and apoptosis (Fu et al., 2000) . The function of sion confers some toxic gain-of-function onto the host protein (Zoghbi and Orr, 2000), we found that larger 14-3-3 binding to ataxin-1 remains unclear, since the cellular function of ataxin-1 is not well understood. The polyglutamine expansions in ataxin-1 have a higher affinity for 14-3-3. 14-3-3 is able to stabilize wild-type present study does, however, shed light on the mecha-late ␣-synuclein (Kawamoto et al., 2002) . Interestingly, ␣-synuclein shares sequence homology with 14-3-3 and binds both to 14-3-3 and to some 14-3-3 binding partners (Ostrerova et al., 1999 ). This finding suggests a possible role for either 14-3-3 or 14-3-3 binding proteins in ␣-synuclein-induced pathology. Moreover, 14-3-3 was recently found to associate with ␣-synuclein in a soluble protein complex that mediates dopaminedependent neurotoxicity (Xu et al., 2002) . It would be interesting to determine whether 14-3-3 plays any role in stabilizing ␣-synuclein. When searching for consensus 14-3-3 binding motifs in other polyglutamine-containing proteins, we found the RXXSXP motif in ataxin-2, ␣1A subunit voltage-gated calcium channel, ataxin-7, and atrophin-1. Further studies are necessary to determine if there is an interaction between these proteins and 14-3-3 and whether such interactions affect the pathogenesis of SCA2, SCA6, SCA7, and DRPLA, respectively.
PI3K/Akt Signaling and Neurodegeneration
Akt phosphorylates ataxin-1 and promotes its binding to 14-3-3, which in turn leads to ataxin-1 accumulation and neurodegeneration (Figure 7) . Loss of dAkt1 function suppressed ataxin-1-induced neurodegeneration in a dosage-dependent manner. Akt is activated when recruited to the plasma membrane and phosphorylated at T308 and S473 by PDK1 and a yet-to-be identified "S473-kinase" (Brazil et al. 2002) . That dPI3K overexpression aggravates the SCA1 phenotype more than dAkt1 overexpression is consistent with the important role of dPI3K in fully activating the signaling cascade ). 14-3-were flattened and signal was quantified using ImageJ software. 3⑀ and 14-3-3 cDNAs were C-terminally tagged with haemagglutinin Average signal from seven samples for every genotype was calcu-(HA)-and myc-epitopes respectively by PCR (Primer sequences lated and plotted using Excel software. shown in Supplemental Table S1 available online at http://cgi/ content/full/113/4/457/DC1). The products were inserted into pIRES2 (Clontech) to make a bi-cistronical expression plasmid Drosophila Genetics pIRES-HA-14-3-3 ⑀/myc-14-3-3. Myc-14-3-3 was subcloned into Drosophila 14-3-3⑀ was inserted in the pUAST vector for generating pcDNA3.1 (Invitrogen). pUSEamp-Akt1 (N-terminal myristoylation) one UAS-d14-3-3⑀ transgenic line. Thirty-two new UAS-d14-3-3⑀ and pUSEamp-Akt1 K179M (Upstate) expressed constitutively aclines were generated by mobilization of the original line with transpotive and dominant negative-Akt1.
sase and then crossed with the weak line SCA1 82Q [F7]/gmr-GAL4 at 23ЊC. The d14-3-3⑀ transgenic lines were classified (weak/strong) based on their ability to produce synthetic lethality over SCA1 82Q .
Immunoprecipitation, Mass Spectrometry,
The null allele 14-3-3⑀ ex4 was generated by imprecise mobilization and Western Blotting Analysis of the P element insertion 14-3-3⑀ j2B10 . Females of the strong y w Cell transfections were done by Lipofectamine 2000 (Invitrogen). 
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